Invasive Ductal Breast Carcinoma clinical trials

Explore recruiting invasive ductal breast carcinoma clinical trials.

Recruiting invasive ductal breast carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Invasive Ductal Breast Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.

Italy, Belgium, Germany, Spain, France, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors

Germany, Portugal, France, Spain, Denmark

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Invasive Ductal Breast Carcinoma trials by city

Invasive Ductal Breast Carcinoma in Toronto Invasive Ductal Breast Carcinoma in Vancouver Invasive Ductal Breast Carcinoma in Montreal Invasive Ductal Breast Carcinoma in Calgary Invasive Ductal Breast Carcinoma in Edmonton Invasive Ductal Breast Carcinoma in Ottawa Invasive Ductal Breast Carcinoma in Winnipeg Invasive Ductal Breast Carcinoma in Quebec City Invasive Ductal Breast Carcinoma in Hamilton Invasive Ductal Breast Carcinoma in Kitchener Invasive Ductal Breast Carcinoma in London Invasive Ductal Breast Carcinoma in Halifax Invasive Ductal Breast Carcinoma in New York Invasive Ductal Breast Carcinoma in Los Angeles Invasive Ductal Breast Carcinoma in Chicago Invasive Ductal Breast Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease